Inventor · disambiguated record
Hartmut Beck
Also filed as: BECK HARTMUT
22 granted patents·17 pending applications·78 citations·filing 2005–2023
93Inventor score
Top patents by PatentIndex Score
39 records- 0187US9771352B2Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2015·Granted Sep 26, 2017·8 cites·15 claims
- 0287US8389520B2Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesTHEDE KAI·Filed 2007·Granted Mar 5, 2013·8 cites·10 claims
- 0387US8067407B2Substituted dihydropyrazolones and their useJESKE MARIO·Filed 2009·Granted Nov 29, 2011·10 cites·21 claims
- 0487US7776922B2Substituted [(phenylethanoyl)amino]benzamidesBAYER SCHERING PHARMA AG·Filed 2005·Granted Aug 17, 2010·16 cites·7 claims
- 0585US8653111B2Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesTHEDE KAI·Filed 2012·Granted Feb 18, 2014·7 cites·14 claims
- 0682US8470811B2Substituted heterocyclylbenzylpyrazoles and use thereofHAERTER MICHAEL·Filed 2011·Granted Jun 25, 2013·12 cites·9 claims
- 0781US8524699B2Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitorsTHEDE KAI·Filed 2007·Granted Sep 3, 2013·6 cites·10 claims
- 0878US8609698B2Substituted dipyridyl-dihydropyrazolones and use thereofTHEDE KAI·Filed 2007·Granted Dec 17, 2013·4 cites·14 claims
- 0977US8580778B2Substituted dihydropyrazolones and their useJESKE MARIO·Filed 2011·Granted Nov 12, 2013·3 cites·36 claims
- 1074US11912692B2Substituted S-alaninate derivativesBAYER AG·Filed 2023·Granted Feb 27, 2024·0 cites·17 claims
- 1172US9168249B2Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesBAYER IP GMBH·Filed 2015·Granted Oct 27, 2015·1 cites·2 claims
- 1272US8987261B2Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesBAYER IP GMBH·Filed 2013·Granted Mar 24, 2015·1 cites·7 claims
- 1369US8183246B2Acyclically substituted furopyrimidine derivatives and use thereofLAMPE THOMAS·Filed 2006·Granted May 22, 2012·1 cites·9 claims
- 1465US8796253B2Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBOYER STEPHEN·Filed 2008·Granted Aug 5, 2014·1 cites·20 claims
- 1563US2025002483A1Substituted s-alaninate derivativesBAYER AG·Filed 2022·Application pending·0 cites
- 1656US2014038938A1Substituted dihydropyrazolones and their useBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 1754US2016229858A1Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesBAYER IP GMBH·Filed 2015·Application pending·0 cites
- 1852US10479765B2Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agentsBayer Pharma AG·Filed 2018·Granted Nov 19, 2019·0 cites·10 claims
- 1949US8076285B2Lysobactin amidesVON NUSSBAUM FRANZ·Filed 2008·Granted Dec 13, 2011·0 cites·20 claims
- 2049US2011166163A1Substituted furopyrimidines and use thereofBAYER SCHERING PHARMA AG·Filed 2008·Application pending·0 cites
- 2148US8003787B2Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2008·Granted Aug 23, 2011·0 cites·21 claims
- 2248US2010261736A1Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular diseaseLAMPE THOMAS·Filed 2008·Application pending·0 cites
- 2347US2011312930A1Aryl compounds with aminoalkyl substituents and their useHAERTER MICHAEL·Filed 2009·Application pending·0 cites
- 2447US2013196964A1Heterocyclically substituted aryl compounds as hif inhibitorsHAERTER MICHAEL·Filed 2009·Application pending·0 cites
- 2547US2011301122A1Heteroaromatic compounds for use as hif inhibitorsHAERTER MICHAEL·Filed 2009·Application pending·0 cites
- 2645US2014329797A1Substituted oxadiazolyl pyridinones and oxadiazolyl pyridazinones as hif inhibitorsBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 2744US8324222B2Cyclically substituted furopyrimidine derivatives and use thereofLAMPE THOMAS·Filed 2006·Granted Dec 4, 2012·0 cites·8 claims
- 2843US10189788B2Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agentsBayer Pharma AG·Filed 2015·Granted Jan 29, 2019·0 cites·11 claims
- 2941US2008214654A1Substituted Benzyloxy-Phenylmethylamide DerivativesBAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 3041US2017313665A1Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3139US11136296B2Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereofBAYER AG·Filed 2018·Granted Oct 5, 2021·0 cites·13 claims
- 3239US2013172311A1Substituted heterocyclyl benzyl pyrazoles, and use thereofHAERTER MICHAEL·Filed 2011·Application pending·0 cites
- 3338US11149018B2Substituted N-arylethyl-2-aminoquinoline-4-carboxamides and use thereofBAYER AG·Filed 2018·Granted Oct 19, 2021·0 cites·12 claims
- 3436US10117864B2Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereofBayer Pharma AG·Filed 2016·Granted Nov 6, 2018·0 cites·20 claims
- 3536US2013150325A13-(Fluorovinyl)pyrazoles and their useHAERTER MICHAEL·Filed 2012·Application pending·0 cites
- 3632US2017121315A1Heterobicyclically substituted 4-oxobutane acid derivatives and use thereofBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3731US2017022171A12,5-disubstituted cyclopentanecarboxylic acids and their useBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3831US2017119776A1Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereofBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3931US2017114049A12,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratory tract diseasesBayer Pharma AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hartmut Beck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →